Traumatic intracranial lesion prevalence in CT-imaged adults with mild traumatic brain injury receiving dual versus single antiplatelet therapy: a two-center cohort study
- 1Emergency Department, Orléans University, Orléans University Hospital
- 2Sports Medicine Department, Orléans University, Orléans University Hospital
Abstract
Among adults with mild traumatic brain injury (mTBI) who are already receiving antiplatelet therapy, evidence comparing radiographic lesion prevalence between dual and single therapy remains limited. We conducted a retrospective two-center cohort study in two French university hospital emergency departments including adults receiving antiplatelet therapy who presented with mTBI and underwent initial head computed tomography during the index visit. The primary exposure was dual versus single antiplatelet therapy, and the primary outcome was any traumatic intracranial lesion on initial computed tomography. Relative risks were estimated using modified Poisson regression with robust variance; sensitivity analyses additionally adjusted for study center and used propensity score overlap weighting with doubly robust adjustment. Among 1,912 patients, 159 received dual antiplatelet therapy and 1,753 single therapy. Lesions were identified in 31/159 patients (19.5%) receiving dual therapy and 251/1,753 (14.3%) receiving single therapy, yielding an absolute risk difference of 5.2% (95% confidence interval, − 0.5% to 12.2%) and an adjusted relative risk of 1.33 (95% confidence interval, 0.95–1.87). A targeted sensitivity analysis restricted to clearly classified intracranial lesions yielded an adjusted relative risk of 1.26 (95% confidence interval, 0.86–1.85). Within this selected CT-imaged population, dual therapy showed a numerically higher but imprecisely estimated lesion prevalence. The study cannot determine excess risk relative to no antiplatelet therapy or whether this numerical difference represents clinically meaningful hemorrhagic risk.
Related
- Intracranial lesion yield and downstream management after mild traumatic brain injury in emergency department patients receiving antiplatelet therapy: a two-center retrospective cohort study.
- A cross-sectional study of the prevalence and correlates of post-traumatic stress among people attending acceptance and commitment therapy for chronic pain
- Prevalence and associated factors of vitamin B12 deficiency among Vietnamese patients with type 2 diabetes receiving metformin therapy: a cross-sectional study
- Prevalence and impact of Thiopurine S-methyltransferase (TPMT) and Nudix hydrolase 15 (NUDT15) polymorphisms on the occurrence of myelosuppression in Thai patients with inflammatory bowel disease receiving thiopurine therapy.
- Prevalence of intestinal parasites and associated factors among HIV patients receiving antiretroviral therapy at public hospitals in North Shoa Zone, Oromia, Ethiopia: Cross-sectional study
BibTeX
@article{sekulski2026traumatic,
title = {{Traumatic intracranial lesion prevalence in CT-imaged adults with mild traumatic brain injury receiving dual versus single antiplatelet therapy: a two-center cohort study}},
author = {Tifany Sekulski and Fatima Di Padova and Dounia Hamdouche and Romain Jouffroy and Vincent Garrouste},
journal = {Scientific Reports},
year = {2026},
month = sep,
doi = {10.1038/s41598-026-71288-6},
url = {https://doi.org/10.1038/s41598-026-71288-6},
note = {CC BY},
}
RIS
TY - JOUR
TI - Traumatic intracranial lesion prevalence in CT-imaged adults with mild traumatic brain injury receiving dual versus single antiplatelet therapy: a two-center cohort study
AU - Tifany Sekulski
AU - Fatima Di Padova
AU - Dounia Hamdouche
AU - Romain Jouffroy
AU - Vincent Garrouste
PY - 2026
DA - 2026/09/01
JO - Scientific Reports
DO - 10.1038/s41598-026-71288-6
UR - https://doi.org/10.1038/s41598-026-71288-6
AB - Among adults with mild traumatic brain injury (mTBI) who are already receiving antiplatelet therapy, evidence comparing radiographic lesion prevalence between dual and single therapy remains limited. We conducted a retrospective two-center cohort study in two French university hospital emergency departments including adults receiving antiplatelet therapy who presented with mTBI and underwent initial head computed tomography during the index visit. The primary exposure was dual versus single antiplatelet therapy, and the primary outcome was any traumatic intracranial lesion on initial computed tomography. Relative risks were estimated using modified Poisson regression with robust variance; sensitivity analyses additionally adjusted for study center and used propensity score overlap weighting with doubly robust adjustment. Among 1,912 patients, 159 received dual antiplatelet therapy and 1,753 single therapy. Lesions were identified in 31/159 patients (19.5%) receiving dual therapy and 251/1,753 (14.3%) receiving single therapy, yielding an absolute risk difference of 5.2% (95% confidence interval, − 0.5% to 12.2%) and an adjusted relative risk of 1.33 (95% confidence interval, 0.95–1.87). A targeted sensitivity analysis restricted to clearly classified intracranial lesions yielded an adjusted relative risk of 1.26 (95% confidence interval, 0.86–1.85). Within this selected CT-imaged population, dual therapy showed a numerically higher but imprecisely estimated lesion prevalence. The study cannot determine excess risk relative to no antiplatelet therapy or whether this numerical difference represents clinically meaningful hemorrhagic risk.
SN - 2045-2322
ER -